| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07557914 | Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for… | HCC - Hepatocellular Carcinoma | Not Yet Recruiting |
| Not specified | |||
| NCT07594834 | Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive… | Lung Cancer | Not Yet Recruiting |